Macular Degeneration Unknown Status Phase 1 / 2 Trials for Disulfiram (DB00822)

Back to Macular Degeneration

Also known as: Macula lutea degeneration / Retinal macula lutea degeneration / Macular luteal degeneration / Degenerative disorder of macula (disorder) / Degeneration macular

Indication	Status	Phase
DBCOND0027875 (Macular Degeneration)	Unknown Status	1 / 2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00745511	Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)	Treatment	Bevacizumab (DB00112) Disulfiram (DB00822)